Cargo Therapeutics (Cargo Therapeutics) Cash-to-Debt : 13.33 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Cargo Therapeutics's cash to debt ratio for the quarter that ended in Mar. 2024 was 13.33.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Cargo Therapeutics could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Cargo Therapeutics's Cash-to-Debt or its related term are showing as below:

CRGX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 12.76 Max: 20.87
Current: 13.33

During the past 3 years, Cargo Therapeutics's highest Cash to Debt Ratio was 20.87. The lowest was 0.01. And the median was 12.76.

CRGX's Cash-to-Debt is ranked better than
59.62% of 1528 companies
in the Biotechnology industry
Industry Median: 6.315 vs CRGX: 13.33

Cargo Therapeutics Cash-to-Debt Historical Data

The historical data trend for Cargo Therapeutics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Cargo Therapeutics Cash-to-Debt Chart

Cargo Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Cash-to-Debt

0.01

0.08

14.22

Cargo Therapeutics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial				N/A	12.20	20.87	14.22	13.33

Competitive Comparison of Cargo Therapeutics's Cash-to-Debt

For the Biotechnology subindustry, Cargo Therapeutics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cargo Therapeutics's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cargo Therapeutics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Cargo Therapeutics's Cash-to-Debt falls into.

Cargo Therapeutics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Cargo Therapeutics's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	405.732	/	(2.278	+	26.263)
	=	14.22

Cargo Therapeutics's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	375.913	/	(1.637	+	26.568)
	=	13.33

Cargo Therapeutics (NAS:CRGX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Cargo Therapeutics Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Cargo Therapeutics's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cargo Therapeutics (Cargo Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Alameda De Las Pulgas, Suite 350, San Mateo, CA, USA, 94403

Website

https://www.cargo-tx.com

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing strategy are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. Their lead program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Cargo Therapeutics (Cargo Therapeutics) Headlines

From GuruFocus

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors

By Marketwired • 04-15-2024